Comparison of BRCT domains of BRCA1 and 53BP1: A biophysical analysis

Protein Science

Volumn 13, Issue 3, 2004, Pages 617-625

  Ekblad, Caroline M S ^a,b,c   Friedler, Assaf ^a,b   Veprintsev, Dmitry ^a,b   Weinberg, Richard L ^a,b   Itzhaki, Laura S ^a,b,c  

^a MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

^b Department of Chemistry ^*  (United Kingdom)

^c HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

Author keywords

53BP1; BRCA1; BRCT; P53

Indexed keywords

BINDING PROTEIN; BRCA1 PROTEIN; GENE PRODUCT; PROTEIN 53BP1; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CALORIMETRY; CARBOXY TERMINAL SEQUENCE; COMPARATIVE ANATOMY; DNA REPAIR; ENERGY; GEL PERMEATION CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; THERMODYNAMICS; TRANSCRIPTION INITIATION; ULTRACENTRIFUGATION;

AMINO ACID SEQUENCE; BINDING SITES; BRCA1 PROTEIN; CALORIMETRY; CARRIER PROTEINS; CHROMATOGRAPHY, GEL; CYSTEINE ENDOPEPTIDASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THERMODYNAMICS; TUMOR SUPPRESSOR PROTEIN P53; ULTRACENTRIFUGATION;

EID: 1342289301     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.03461404     Document Type: Article

References (23)

1. Bullock, A.N., Henckel, J., DeDecker, B.S., Johnson, C.M., Nikolova, P.V., Proctor, M.R., Lane, D.P., and Fersht, A.R. 1997. Thermodynamic stability of wild-type and mutant p53 core domain. Proc. Natl. Acad. Sci. 94: 14338-14342.
2. Chai, Y.L., Cui, J., Shao, N., Shyam, E., Reddy, P., and Rao, V.N. 1999. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene 18: 263-268.
3. Derbyshire, D.J., Basu, B.P., Serpell, L.C., Joo, W.S., Date, T., Iwabuchi, K., and Doherty, A.J. 2002. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J. 21: 3863-3872.
4. DiTullio Jr., R.A., Mochan, T.A., Venere, M., Bartkova, J., Sehested, M., Bartek, J., and Halazonetis, T.D. 2002. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell Biol. 4: 998-1002.
5. Ekblad, C.M., Wilkinson, H.R., Schymkowitz, J.W., Rousseau, F., Freund, S.M., and Itzhaki, L.S. 2002. Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1. J. Mol. Biol. 320: 431-442.
6. Fernandez-Capetillo, O., Chen, H.T., Celeste, A., Ward, I., Romanienko, P.J., Morales, J.C., Naka, K., Xia, Z., Camerini-Otero, R.D., Motoyama, N., et al. 2002. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat. Cell Biol. 4: 993-997.
7. Hainaut, P. and Hollstein, M. 2000. p53 and human cancer: The first 10,000 mutations. Adv. Cancer Res. 77: 81-137.
8. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. 1991. p53 mutations in human cancers. Science 253: 49-53.
9. Huyton, T., Bates, P.A., Zhang, X.D., Sternberg, M.J.E., and Freemont, P.S. 2000. The BRCA1 C-terminal domain: Structure and function. Mutat. Res. DNA Repair 460: 319-332.
10. Iwabuchi, K., Bartel, P.L., Li, B., Marraccino, R., and Fields, S. 1994. Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. 91: 6098-6102.
11. Iwabuchi, K., Li, B., Massa, H.F., Trask, B.J., Date, T., and Fields, S. 1998. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BPI and 53BP2. J. Biol. Chem. 273: 26061-26068.
12. Joo, W.S., Jeffrey, P.D., Cantor, S.B., Finnin, M.S., Livingston, D.M., and Pavletich, N.P. 2002. Structure of the 53BPI BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes & Dev. 16: 583-593.
13. Manke, I.A., Lowery, D.M., Nguyen, A., and Yaffe, M.B. 2003. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302: 636-639.
14. Pierce, M.M., Raman, C.S., and Nall, B.T. 1999. Isothermal titration calorimetry of protein-protein interactions. Methods 19: 213-221.
15. Rappold, I., Iwabuchi, K., Date, T., and Chen, J. 2001. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell. Biol. 153: 613-620.
16. Rodriguez, M., Yu, X., Chen, J., and Songyang, Z. 2003. Phosphopeptide binding specificities of BRCT domains. J. Biol. Chem. 278: 52914-52918.
17. Schultz, L.B., Chehab, N.H., Malikzay, A., and Halazonetis, T.D. 2000. p53 binding protein I (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell. Biol. 151: 1381-1390.
18. Scully, R., Chen, J., Ochs, R.L., Keegan, K., Hoekstra, M., Feunteun, J., and Livingston, D.M. 1997. Dynamic changes of BRCAI subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425-435.
19. Wang, B., Matsuoka, S., Carpenter, P.B., and Elledge, S.J. 2002. 53BP1: A mediator of the DNA damage checkpoint. Science 298: 1435-1438.
20. Williams, R.S., Green, R., and Glover, J.N.M. 2001. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8: 838-842.
21. Yu, X., Chini, C.C., He, M., Mer, G., and Chen, J. 2003. The BRCT domain is a phospho-protein binding domain. Science 302: 639-642.
22. Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Bi, D., Weber, B.L., and El-Deiry, W.S. 1998. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16: 1713-1721.
23. Zhang, X.D., Morera, S., Bates, P.A., Whitehead, P.C., Coffer, A.I., Hainbucher, K., Nash, R.A., Stemberg, M.J.E., Lindahl, T., and Freemont, P.S. 1998. Structure of an XRCC1 BRCT domain: A new protein-protein interaction module. EMBO J. 17: 6404-6411.